NOVA SATRA DX

Nova Satra Dx is a molecular diagnostics company headquartered in Singapore. The company is committed to empowering patients and physicians through the research, development and commercialisation of novel blood based diagnostic tests. These tests provide rapid and accurate detection of cancer using Asian-specific epigenetic biomarkers. Based on its clinically validated NovoTect™ technology developed by the University of Oxford, Nova Satra’s diagnostic tests can detect and identify changes in gene expression which are linked to cancer. The company is developing a pipeline of tests for breast, colon, prostate, stomach and lung cancers. For more information, please visit www.novasatra.com